Impact of the COVID-19 pandemic on temporal trends of biological indicators of autoimmunity
Open Access
- 28 November 2023
- journal article
- research article
- Published by Elsevier in Journal of Translational Autoimmunity
- Vol. 7, 100222
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort studyeClinicalMedicine, 2023
- Pathophysiological mechanisms of thrombosis in acute and long COVID-19Frontiers in Immunology, 2022
- Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysisBMC Medicine, 2022
- COVID-19 and the antiphospholipid syndromeAutoimmunity Reviews, 2022
- Incidence of New-Onset Type 1 Diabetes Among US Children During the COVID-19 Global PandemicJAMA Pediatrics, 2022
- Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on AutoantibodiesAutoimmunity Reviews, 2021
- The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learnedAutoimmunity Reviews, 2021
- Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2Cell Metabolism, 2021
- SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreasNature Metabolism, 2021
- Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19Science Translational Medicine, 2020